St. Jude Offers $1.3 Bil. For ANS, Citing Low-Voltage Technology Synergy
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical cites technological synergies and near-term revenue growth as justification for its offer to acquire Advanced Neuromodulation Systems for $1.3 bil
You may also be interested in...
St. Jude Looks Beyond ICDs To Emerging AF Market For Growth In 2006
St. Jude Medical expects its atrial fibrillation division to be a consistent revenue driver after ICDs due to its broad range of products and growing market opportunity
St. Jude Looks Beyond ICDs To Emerging AF Market For Growth In 2006
St. Jude Medical expects its atrial fibrillation division to be a consistent revenue driver after ICDs due to its broad range of products and growing market opportunity
Boston Scientific Banks On ICDs To Spark Stock Growth; Index Slips In 2005
Boston Scientific is counting on Guidant shareholders preferring its takeover offer to J&J's to regain Wall Street enthusiasm in the face of diminishing competitive advantages for Taxus and a 31% stock decline in 2005